Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerMSS Metastatic Colorectal Cancer; Ras-mutated Metastatic Colorectal Cancer; mCRCRecruitingPhase 22026-10-06NCT07446322

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Oncolytics Biotech4

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beacon Cancer CenterPost FallsUnited States1
Central Alabama ResearchHomewoodUnited States1
Clinical Research Advisors (Beverly Hills)Beverly HillsUnited States1
Clinical Research Advisors (Downtown LA)Los AngelesUnited States1
Clinical Research Advisors (Encino)EncinoUnited States1
Clinical Research Advisors (Korea Town)KoreatownUnited States1
Clinical Research Advisors (West Covina)West CovinaUnited States1
Clinical Research Advisors (West Hollywood)Los AngelesUnited States1
Community Health NetworkIndianapolisUnited States16
Emory Winship Cancer InstituteAtlantaUnited States1
Gabrail Cancer CenterCantonUnited States39
Karmanos Cancer InstituteDetroitUnited States153
Moffitt Cancer CenterTampaUnited States523
Northwestern Memorial HospitalChicagoUnited States129
Rutgers Cancer InstituteNew BrunswickUnited States41
Summit Health Cancer CenterFlorham ParkUnited States1
Washington University School of MedicineSt LouisUnited States895